Acquiring Company
Merck
Acquired Company
Imago BioSciences, Inc.
RahwaySan CarlosManufacturingBiotechnologyHealthcareHealth CareBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalDescription
Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Imago BioSciences, Inc. (“Imago”) (Nasdaq: IMGO) today announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Imago for $36.00 per share in cash for an approximate total equity value of $1.35 billion.
Quick answer
Merck is acquiring Imago BioSciences, Inc., announced November 21, 2022. Merck is based in Rahway, New Jersey, United States.
- Who acquired Imago BioSciences, Inc?
- Merck agreed to acquire Imago BioSciences, Inc. on November 21, 2022.
- How much did Merck pay for Imago BioSciences, Inc?
- The deal value was not disclosed.
- What does Merck do?
- For over 130 years, Merck, known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our..
- Where are Merck and Imago BioSciences, Inc. based?
- Merck is based in Rahway, New Jersey, United States. Imago BioSciences, Inc. is based in San Carlos, California, United States.
- Who are the decision-makers at Merck?
- Fundz holds 3 contacts at Merck. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Healthcare and Healthcare
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Kite To Acquire Tmunity Therapeutics To Pursue Next Generation Car T-Cell Therapy Advancements In Cancer (December 20, 2022)
- Solid Biosciences Announces Closing Of Acquisition Of Aavantibio And Concurrent $75 Million Private Placement, $75M (December 5, 2022)
- Lilly Completes Acquisition Of Akouos Expanding Efforts To Help People With Genetic Diseases (December 1, 2022)
- Solid Biosciences Announces Stockholder Approval Of Acquisition Of Aavantibio (December 1, 2022)
- Atossa Therapeutics, Inc. To Acquire Stake In Privately Held Dynamic Cell Therapies As Part Of Overall Car-T Strategy (November 1, 2022)
- Lilly To Acquire Akouos To Discover And Develop Treatments For Hearing Loss (October 18, 2022)
Who to call at Merck, and when
When Merck changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Merck raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Merck, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Merck. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Merck makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Imago BioSciences, Inc.?
Imago BioSciences, Inc. was acquired by Merck, based in Rahway. The deal was reported on November 21, 2022. Merck is publicly traded (MRK) and operates in Manufacturing.
When did Merck acquire Imago BioSciences, Inc.?
Merck's acquisition of Imago BioSciences, Inc. was reported on November 21, 2022. Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Imago BioSciences, Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Imago BioSciences, Inc. do?
It is privately held, operating in Biotechnology, and is based in San Carlos.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.